{"id":"hdg1901","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Without access to detailed clinical trial data or published literature on HDG1901, the precise molecular target and mechanism cannot be reliably determined. The drug remains in Phase 3 development, suggesting it has shown promise in earlier trials, but mechanistic details are typically proprietary until regulatory approval or formal publication.","oneSentence":"HDG1901 is an investigational drug in Phase 3 development by Hangzhou Zhongmei Huadong Pharmaceutical, but its specific mechanism of action is not publicly disclosed.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:15:05.913Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT06634927","phase":"PHASE1","title":"Pharmacokinetic Similarity, Safety, and Immunogenicity of Semaglutide Injection and Ozempic ® Injection in Healthy Subjects.","status":"COMPLETED","sponsor":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","startDate":"2024-09-22","conditions":"Type 2 Diabetes","enrollment":68},{"nctId":"NCT06739044","phase":"PHASE3","title":"Efficacy and Safety of Semaglutide Injection vs Ozempic® in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","startDate":"2023-09-20","conditions":"Type 2 Diabetes","enrollment":494}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"HDG1901","genericName":"HDG1901","companyName":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","companyId":"hangzhou-zhongmei-huadong-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}